Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
09/27/20249:42AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BRCBrady Corp
09/27/20249:42AMPR Newswire (US)Surety One, Inc. Backs The Me Fine Foundation, Strengthening The Families of Critically Ill Children
09/27/20249:41AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XNCRXencor Inc
09/27/20249:41AMPR Newswire (Canada)CMI Financial Group places 119th on The Globe and Mail's sixth annual ranking of Canada's Top Growing Companies
09/27/20249:39AMBusiness WireSafeguard Against Credit Application Fraud with Bectran and Cobalt Integration
09/27/20249:37AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:CULPCulp Inc
09/27/20249:36AMEdgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]AMEX:RYDERyde Group Ltd
09/27/20249:36AMPR Newswire (Canada)Propel Places on The Globe and Mail's sixth annual ranking of Canada's Top Growing CompaniesTSX:PRLPropel Holdings Inc
09/27/20249:35AMGlobeNewswire Inc.CannabisNewsWire is a Gold Sponsor and Official NewsWire for the Grow Up Conference & Expo
09/27/20249:35AMGlobeNewswire Inc.Dupixent® (dupilumab) Approved in the U.S. as the First-ever Biologic Medicine for Patients with COPDNASDAQ:SNYSanofi
09/27/20249:35AMGlobeNewswire Inc.Dupixent® (dupilumab) Approved in the U.S. as the First-ever Biologic Medicine for Patients with COPDEU:SANSanofi
09/27/20249:35AMGlobeNewswire Inc.Dupixent® (dupilumab) Approved in the U.S. as the First-ever Biologic Medicine for Patients with COPDNASDAQ:REGNRegeneron Pharmaceuticals Inc
09/27/20249:35AMGlobeNewswire Inc.Press Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPDEU:SANSanofi
09/27/20249:34AMBusiness WireFifth Third Named a 2024 Leading Disability Employer by the National Organization on DisabilityNASDAQ:FITBFifth Third Bancorp
09/27/20249:33AMBusiness WireLTIMindtree Strengthens Partnership with Currys
09/27/20249:30AMAlliance NewsAlliance NewsGermany confirms Biden visit and Ukraine allies meeting
09/27/20249:30AMPR Newswire (US)GAHL ANNOUNCES STRATEGIC AND FINANCIALLY ACCRETIVE ACQUISITION
09/27/20249:29AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WORWorthington Enterprises Inc
09/27/20249:29AMBusiness WireTachus Fiber Internet Celebrates Achieving 50,000 Customers With Family in Kingwood, Texas
09/27/20249:29AMPR Newswire (US)BetterHelp Partners with Talkiatry to Offer Therapy & Psychiatric Services to Businesses
09/27/20249:28AMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SNAXStryve Foods Inc
09/27/20249:27AMAlliance NewsAlliance NewsFOREX MARKET: Dollar weakens after US data; yen jumps after Ishiba win
09/27/20249:27AMGlobeNewswire Inc.Qifu Technology Responds to Short Seller ReportNASDAQ:QFINQifu Technology Inc
09/27/20249:27AMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:KNWKnow Labs Inc
09/27/20249:26AMAlliance NewsAlliance NewsEARNINGS: Blackrock Latin opts for patience as net asset value fallsLSE:TECHTechfinancials Inc
09/27/20249:26AMAlliance NewsAlliance NewsEARNINGS: Blackrock Latin opts for patience as net asset value fallsLSE:GLRGalileo Resources Plc
09/27/20249:26AMAlliance NewsAlliance NewsEARNINGS: Blackrock Latin opts for patience as net asset value fallsLSE:XTRXtract Resources Plc
09/27/20249:26AMAlliance NewsAlliance NewsEARNINGS: Blackrock Latin opts for patience as net asset value fallsLSE:BRLABlackrock Latin American Investment Trust Plc
09/27/20249:26AMAlliance NewsAlliance NewsEARNINGS: Blackrock Latin opts for patience as net asset value fallsAQSE:IQOInteliqo Limited
09/27/20249:26AMAlliance NewsAlliance NewsEARNINGS: Blackrock Latin opts for patience as net asset value fallsLSE:TECHTechfinancials Inc